Oral Chemotherapy Food and Drug Interactions: A Comprehensive Review of the Literature

被引:56
|
作者
Segal, Eve M. [1 ]
Flood, Megan R.
Mancini, Robert S.
Whiteman, Robert T.
Friedt, Gregory A.
Kramer, Adam R.
Hofstetter, Mark A.
机构
[1] Froedtert & Med Coll Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA
关键词
D O I
10.1200/JOP.2013.001183
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Oral chemotherapy is rapidly becoming a popular dosage form for cancer treatment. These medications have a narrow therapeutic index, and their metabolism can be easily affected by food and/or drug interactions. These interactions can significantly reduce the effectiveness of oral chemotherapy, which could possibly result in harm to patients. Methods: A systematic evaluation of 58 oral chemotherapeutics was conducted. Drug and food interactions were analyzed using US Food and Drug Administration-approved product labeling, primary literature, and tertiary databases. Results: Our evaluation identified information about drug and food interactions. We present the recommended dose adjustments in our article. Conclusion: Oral chemotherapy is associated with a significant number of medication and food interactions. It is essential that health care providers evaluate patients' diet and concurrent medications to provide accurate patient education, therapeutic monitoring, and, if necessary, alternative recommendations whenever oral chemotherapy is prescribed.
引用
收藏
页码:E255 / E268
页数:14
相关论文
共 50 条
  • [1] A Review of Food–Drug Interactions on Oral Drug Absorption
    Jianyuan Deng
    Xiao Zhu
    Zongmeng Chen
    Chun Ho Fan
    Him Shek Kwan
    Chi Ho Wong
    Ka Yi Shek
    Zhong Zuo
    Tai Ning Lam
    Drugs, 2017, 77 : 1833 - 1855
  • [2] A Review of Food-Drug Interactions on Oral Drug Absorption
    Deng, Jianyuan
    Zhu, Xiao
    Chen, Zongmeng
    Fan, Chun Ho
    Kwan, Him Shek
    Wong, Chi Ho
    Shek, Ka Yi
    Zuo, Zhong
    Lam, Tai Ning
    DRUGS, 2017, 77 (17) : 1833 - 1855
  • [3] Clinical Outcomes Associated with Drug–Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review
    Manvi Sharma
    Aisha Vadhariya
    Soumya Chikermane
    Suma Gopinathan
    Mariana Chavez-MacGregor
    Sharon H. Giordano
    Michael L. Johnson
    Holly M. Holmes
    Drugs & Aging, 2019, 36 : 341 - 354
  • [4] Clinical outcomes associated with drug-drug interactions of Oral chemotherapeutic agents: A comprehensive evidence-based literature review
    Sharma, Manvi
    Vadhariya, Aisha
    Chikermane, Soumya
    Gopinathan, Suma
    Chavez-MacGregor, Mariana
    Giordano, Sharon H.
    Johnson, Michael L.
    Holmes, Holly M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 197 - 197
  • [5] Clinical Outcomes Associated with Drug-Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review
    Sharma, Manvi
    Vadhariya, Aisha
    Chikermane, Soumya
    Gopinathan, Suma
    Chavez-MacGregor, Mariana
    Giordano, Sharon H.
    Johnson, Michael L.
    Holmes, Holly M.
    DRUGS & AGING, 2019, 36 (04) : 341 - 354
  • [6] Impact of Food Physical Properties on Oral Drug Absorption: A Comprehensive Review
    Wang, Ziyang
    Xu, Wen
    Liu, Dan
    Li, Xiuqi
    Liu, Shupeng
    Wu, Xiaofei
    Wang, Hongyun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 267 - 280
  • [7] A Comprehensive Review of Drug–Drug Interactions with Metformin
    Tore Bjerregaard Stage
    Kim Brøsen
    Mette Marie Hougaard Christensen
    Clinical Pharmacokinetics, 2015, 54 : 811 - 824
  • [8] Review of Drug Interactions: A Comprehensive Update
    Mutalik, Madhav
    Sanghavi, Dhara
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (08): : 954 - 980
  • [9] Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature
    Andrus, MR
    PHARMACOTHERAPY, 2004, 24 (02): : 285 - 290
  • [10] A Comprehensive Review of Drug-Drug Interactions with Metformin
    Stage, Tore Bjerregaard
    Brosen, Kim
    Christensen, Mette Marie Hougaard
    CLINICAL PHARMACOKINETICS, 2015, 54 (08) : 811 - 824